29 results on '"Li, Liu‐Cheng"'
Search Results
2. Statin-Associated Liver Dysfunction and Muscle Injury: epidemiology, Mechanisms, and Management Strategies.
3. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review
4. Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidence
5. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
6. Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidence.
7. Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication
8. Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies
9. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China
10. Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study
11. Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection
12. Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection.
13. Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019
14. Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management
15. Emerging role of HMGB1 in fibrotic diseases
16. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats
17. Enhancing antioxidant, antimicrobial and anti‐NSCLC activities of (‐)‐epigallocatechin gallate encapsulated poly(butyl‐2‐cyanoacrylate) nanowires applications in dietary supplements
18. Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
19. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation
20. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
21. Benefits of the active agents from Yupingfeng for pulmonary fibrosis
22. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling
23. Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4
24. Emerging role of HMGB 1 in fibrotic diseases
25. Functions of Galectin-3 and Its Role in Fibrotic Diseases
26. Total polysaccharide of Y upingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
27. Inositol-requiring protein 1 – X-box-binding protein 1 pathway promotes epithelial–mesenchymal transition via mediating snail expression in pulmonary fibrosis.
28. Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature.
29. [Study of plasma temperature measurements for oxygen discharge].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.